To identify relationship between the clinical outcome of patients and single nucleotide polymorphisms (SNPs) of the PD-1 protein-coding gene (PDCD1) in patients with metastatic renal cell carcinoma (mRCC)
Latest Information Update: 27 Oct 2021
At a glance
- Drugs Ipilimumab (Primary) ; Nivolumab (Primary)
- Indications Renal cell carcinoma
- Focus Adverse reactions; Pharmacogenomic; Therapeutic Use
- 27 Oct 2021 New trial record
- 13 Sep 2021 Results presented at the 116th Annual Meeting of the American Urological Association